Phase II trial of concurrent erlotinib in locally advanced non-small cell lung cancer (LA-NSCLC)

被引：1
|
作者：
Hansen, O. [1 ]
Knap, M. [2 ]
Khalil, A. [2 ]
Nyhus, C. [3 ]
Brink, C. [4 ]
Hoffmann, L. [5 ]
Schytte, T. [1 ]
机构：
[1] Odense Univ Hosp, Oncol, Odense, Denmark
[2] Aarhus Univ Hosp, Oncol, Aarhus, Denmark
[3] Vejle Hosp, Oncol, Vejle, Denmark
[4] Odense Univ Hosp, Lab Radiat Phys, Odense, Denmark
[5] Aarhus Univ Hosp, Med Phys, Aarhus, Denmark
来源：
RADIOTHERAPY AND ONCOLOGY | 2017年 / 123卷
关键词：
D O I：
10.1016/S0167-8140(17)31664-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-1229
引用
收藏
页码：S663 / S663
页数：1
相关论文
共 50 条
  • [21] A phase II trial of induction therapy with gemcitabine and carboplatin followed by concurrent gemcitabine and radiotherapy in locally advanced non-small cell lung cancer (NSCLC)
    Thongprasert, S
    Sukthomya, V
    Charoentum, C
    Pojchamarnwiputh, S
    Saengsawang, P
    LUNG CANCER, 2005, 49 : S393 - S393
  • [22] Toxicities and compliance to treatment in locally advanced non-small cell lung cancer (LA-NSCLC) treated with concurrent chemoradiotherapy (cCTRT) at the Christie NHS Foundation Trust
    Mehmood, Q.
    Ashcroft, L.
    Bayman, N.
    Blackhall, F.
    Burt, P.
    Chittalia, A.
    Coote, J.
    Fenemore, J.
    Halkyard, E.
    Harris, M.
    Lee, L.
    Pemberton, L.
    Sheikh, H.
    Taylor, P.
    Faivre-Finn, C.
    LUNG CANCER, 2013, 79 : S63 - S64
  • [23] A phase II study of cisplatin (P), S-1 (S), and concurrent thoracic radiotherapy (TRT) for locally advanced non-small cell lung cancer (LA-NSCLC): Okayama Lung Cancer Study Group trial 0501.
    Kishino, Daizo
    Nogami, Naoyuki
    Segawa, Yoshihiko
    Aoe, Keisuke
    Ueoka, Hiroshi
    Takigawa, Nagio
    Harita, Shingo
    Tabata, Masahiro
    Tanimoto, Mitsune
    Kiura, Katsuyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [24] Higher Radiation Dose to Immune Cells is a Negative Prognostic Factor in Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC)
    Friedes, C.
    Yegya-Raman, N.
    Iocolano, M.
    Lee, S. H.
    Su, W.
    Duan, L.
    Li, B.
    Doucette, A.
    Cohen, R.
    Aggarwal, C.
    Levin, W.
    Cengel, K.
    Teo, K.
    Langer, C.
    Xiao, Y.
    Bradley, J.
    Feigenberg, S.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S576 - S576
  • [25] Erlotinib in progressive pretreated advanced non-small cell lung cancer (NSCLC): Results of a phase II open-label trial
    Piantedosi, F., V
    Gilli, M.
    Caputo, F.
    Casale, B.
    Bianco, A.
    Dericoloso, A.
    Pontillo, A.
    Crispino, C.
    Giuliarini, G.
    Hengheller, M.
    Chianca, P.
    ANNALS OF ONCOLOGY, 2007, 18 : 26 - 26
  • [26] Concurrent chemo-radiotherapy in locally advanced non-small cell lung cancer (NSCLC): A multicenter randomized phase II study
    Bouillet, T
    Diana, C
    Pailler, M
    Gozy, M
    Labrune, S
    Gervais, R
    Brechot, J
    Breau, J
    Chinet, T
    Morere, J
    LUNG CANCER, 2005, 49 : S166 - S167
  • [27] A phase II study of erlotinib and sorafenib in chemotherapy-naive patients with locally advanced/metastatic non-small cell lung cancer (NSCLC)
    Lind, Joline S.
    Dingemans, Anne-Marie C.
    Groen, Harry J.
    Smit, Egbert F.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S412 - S413
  • [28] A phase II study of erlotinib and sorafenib in chemotherapy-naive patients with locally advanced/metastatic non-small cell lung cancer (NSCLC)
    Lind, J. S.
    Dingemans, A. C.
    Groen, H. J.
    Smit, E. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [29] Concurrent Chemoradiation in Locally Advanced, Unresectable Non Small-cell Lung Cancer (LA-NSCLC): Comparison of Efficacy and Treatment Tolerance in the Elderly
    Collen, C.
    Van Brummelen, D.
    Versmessen, H.
    Bral, S.
    Schallier, D.
    De Greve, J.
    De Ridder, M.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S276 - S276
  • [30] RETROSPECTIVE DOSIMETRY STUDY ANALYSING THE ROLE OF IMRT IN LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER (LA-NSCLC) PATIENTS.
    Nulens, A.
    Mousa, A.
    Swinnen, A.
    Dirix, R.
    De Wever, W.
    Stroobants, S.
    Lievens, Y.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S421 - S421
12345